Its obvious isn't it ? From an ethical, procedural and regulatory point of view. Why is this so hard to understand. Even AI concurs! lol..
No, clinical trials cannot be commenced without sufficient funding in place. Clinical trials are expensive, requiring resources for personnel, facilities, materials, and data analysis. Without adequate funding, it's impossible to conduct the trial, collect and analyze data, and ultimately determine the efficacy or safety of a new treatment or intervention. Here's why full funding is crucial: Operational Costs:Trials require a significant budget for personnel (researchers, nurses, data managers, etc.), facility rentals or maintenance, and the purchase of necessary equipment and materials.Data Collection and Analysisata from clinical trials needs to be collected, stored, and analyzed to provide meaningful results. This requires specialized software, personnel, and potentially external data analysis services, all of which need funding.Regulatory Compliance:Clinical trials must adhere to strict regulatory requirements, which often involve costs for paperwork, inspections, and audits.Patient Support:Some trials may require additional patient support, such as travel costs, accommodation, or other expenses, which need to be budgeted for.In summary, while it's possible to secure partial funding or explore different funding models, a clinical trial cannot be launched successfully without a clear plan for covering all necessary expenses.
- Forums
- ASX - By Stock
- PAR
- Where are we on a deal?
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.48%
!
32.0¢

Where are we on a deal?, page-1138
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
32.0¢ |
Change
-0.015(4.48%) |
Mkt cap ! $124.6M |
Open | High | Low | Value | Volume |
33.5¢ | 34.0¢ | 31.5¢ | $215.7K | 663.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 30081 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 10905 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8058 | 0.315 |
1 | 16129 | 0.310 |
1 | 50000 | 0.305 |
2 | 52500 | 0.300 |
3 | 117880 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 10905 | 1 |
0.330 | 10 | 1 |
0.335 | 3500 | 1 |
0.340 | 113110 | 3 |
0.350 | 53621 | 7 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online